Sjogrens Syndrome Measured by Ultrasound



Status:Recruiting
Conditions:Rheumatology
Therapuetic Areas:Rheumatology
Healthy:No
Age Range:18 - 65
Updated:1/28/2018
Start Date:May 2016
End Date:December 2019
Contact:Theresa Bass-Goldman
Email:tbgoldman@arapc.com
Phone:301 942-6610

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

Disease Modification in Sjogrens Syndrome Measured by Ultrasound: A Pilot Study

Ultrasound study focused on salivary gland outcomes in Sjogren's subjects

A 32 week ultrasound study for subject diagnosed with Sjogren's Syndrome. Subjects will
receive Orencia (Abatacept) as intervention therapy during this trial.

Inclusion Criteria:

- Subjects diagnosed with Sjogren's Syndrome

Exclusion Criteria:

- Subjects previously diagnosed with Sarcoidsis

- Subjects with positive for Hepatitis B, Hepatitis C, HIV

- Subjects diagnosed with Cancer within 5 years of screening
We found this trial at
1
site
The Center for Rheumatology and Bone Research a division of Arthritis and Rheumatism Associates, P.C.
2730 University Boulevard West
Wheaton, Maryland 20902
Principal Investigator: Paul J DeMarco, MD
Phone: 301-942-6610
?
mi
from
Wheaton, MD
Click here to add this to my saved trials